RSS Feed
Featured Posts

Highly effective tumor detection strategy for common childhood brain tumors

A team of scientists have developed a way to more accurately both detect and monitor a common type of pediatric brain cancer, setting the stage for giving clinicians a real-time view into how the cancer responds to treatment. Read more: https://www.sciencedaily.com/releases/2020/10/201021163932.htm

Pediatric cancers share stalled gene-managing enzyme

A wildly out-of-place protein leads to haywire cells in a particularly troublesome type of rare early childhood cancer, according to University of Wisconsin–Madison researchers. Read more: https://news.wisc.edu/pediatric-cancers-share-stalled-gene-managing-enzyme/

CAR NKT cells offer a promising novel immunotherapy for solid tumors

Natural killer T (NKT) cells, a type of immune cells known for their potent anti-cancer properties in murine tumor models, have been developed into a novel form of immunotherapy to treat patients with cancer. Read more: https://medicalxpress.com/news/2020-10-car-nkt-cells-immunotherapy-solid.html

ICR to study fadraciclib to treat paediatric neuroblastoma

The Institute of Cancer Research (ICR) in the UK is set to conduct clinical trials of a new drug candidate, fadraciclib, to potentially treat the aggressive childhood cancer neuroblastoma. Read more: https://www.clinicaltrialsarena.com/news/icr-fadraciclib-neuroblastoma/

Promising treatment for aggressive childhood cancer

A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study was led by researchers at Lund University in Sweden, and is published in the journal Science Translational Medicine. Read more: https://medicalxpress.com/news/2020-10-treatment-aggressive-childhood-cancer.html

Childhood chemo alters heart's caretaker cells, study finds

Cancer chemotherapy changes the function of cells that repair heart injury, researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) discovered. Twenty percent of children treated with drugs called anthracyclines go on to suffer heart failure later in life. Read more: https://medicalxpress.com/news/2020-09-childhood-chemo-heart-caretaker-cells.html

Recent Posts
Archive
Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • YouTube Social  Icon

524 Bayfield Street North
P.O. Box 20005
Barrie, ON L4M 5E9
Canada

info@opacc.org

1-888-290-5496

  • Wix Facebook page
  • Wix Twitter page
  • Instagram Social Icon
  • LinkedIn Social Icon
  • YouTube Social  Icon